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http://dx.doi.org/10.1016/j.stemcr.2016.06.006SUMMARYEmbryonic stem cells (ESCs), which are derived from a peri-implantation embryo, are routinely cultured in medium containing diabetic
glucose (Glc) concentrations.While pregnancy in womenwith pre-existing diabetesmay result in small embryos, whether such highGlc
levels affect ESC growth remains uncovered. We show here that long-term exposure of ESCs to diabetic Glc inhibits their proliferation,
therebymimicking in vivo findings.Molecularly, Glc exposure increased oxidative stress and activated Forkhead boxO3a (FOXO3a), pro-
moting increased expression and activity of the ROS-removal enzymes superoxide dismutase and catalase and the cell-cycle inhibitors
p21cip1 and p27kip1. DiabeticGlc also promoted b-cateninnuclear localization and the formation of a complexwith FOXO3a that localized
to the promoters of Sod2, p21cip1, and potentially p27kip1. Our results demonstrate an adaptive response to increases in oxidative stress
induced by diabetic Glc conditions that promote ROS removal, but also result in a decrease in proliferation.INTRODUCTION
Because of the many similarities to a pre-implantation em-
bryo, embryonic stem cells (ESCs) are a powerful model of
early embryogenesis that can be used to examine the
molecular mechanism underlying cell-fate specification.
Furthermore, and especially due to their reliance on glycol-
ysis to produce energy (Cho et al., 2006), which they share
with cancer cells, any insight into their extensive prolifer-
ative potential may provide novel clues to understanding
cellular responses in cells that proliferate indefinitely, but
do not become transformed.
ESCs were first discovered in 1981 independently by two
groups (Martin, 1981; Evans and Kaufmann, 1981) and,
while they were initially cultivated in medium containing
physiological glucose (Glc) concentrations of 5.5 mM, de-
scriptions of their routine cultivation in 25 mM Glc can
be traced back to reports published as early as 1987
(Doetschman et al., 1987). It is unclear why this switch in
culture conditions occurred, especially since newer reports
suggest that ESC derivation ismore successful in physiolog-
ical Glc by increasing the pool of proliferating cells (Wang
et al., 2006). The mechanism by which normoglycemia
supports proliferation is currently unknown, although
the same study illustrating that exposure to hyperglycemia
leads to an increase in reactive oxygen species (ROS) may
provide an important first step in elucidating the connec-
tion between hyperglycemia and complications during
ESC establishment and growth.
The beneficial effect of physiological Glc concentrations
on ESC proliferation is in line with in vivo findings fromS
This is an open access article under the Cdiabetic pregnancies, in which poorly controlled blood
Glc levels result in embryos that are small in size, possibly
due to a decrease in proliferation mediated by hyperglyce-
mia-induced overactivation of p21cip1 (Zanetti et al., 2001;
Varma et al., 2005; Scott-Drechsel et al., 2013).
These in vivo data and the newer studies suggesting a
beneficial effect of physiological Glc on ESC growth are
in contrast to a previous study, in which a high Glc envi-
ronment resulted in an increase in ESC proliferation (Kim
et al., 2006). Molecularly, Glc may increase proliferation
of cells through various mechanisms, including increased
phosphorylation and inhibition of forkhead box O tran-
scription factors (FOXOs). As FOXO proteins have been
suggested to transcriptionally regulate the cell-cycle inhib-
itory genes p21cip1 and p27kip1 (Dijkers et al., 2000; Hauck
et al., 2007), the inhibition of these transcription factors
and the consequent inhibition of cell-cycle inhibitors
would contribute to extensive cellular proliferation. In
line with this notion, Kim et al. (2006) found that hyper-
glycemia activated the serine/threonine kinase AKT in
ESCs, a known upstream regulator of FOXO nuclear exclu-
sion (Dickson et al., 2001).
Due to this apparent controversy, we sought to examine
exposure of ESCs to high Glc levels for longer than 12 hr, as
was done by Kim et al. (2006), to investigate whether this
longer exposure would be able to mimic the in vivo effects
of Glc on the early embryo and represent the conditions
found during ESC derivation. Indeed, in acute exposures
(5 days), we found decreased proliferation. We further sug-
gest that a molecular cascade involving oxidative stress, in-
hibition of AKT, activation of c-jun NH2-terminal kinasetem Cell Reports j Vol. 7 j 55–68 j July 12, 2016 j ª 2016 The Authors. 55
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Hyperglycemia Leads to a Decrease in Cell Number and Is Coupled with an Increase in Oxidative Stress
(A) Micrographs of D3 ESCs exposed to varying Glc concentrations.
(B) Cell counts demonstrated that brief hyperglycemic exposure led to an initial increase in cell numbers, but these numbers were
decreased after 5 days of exposure. n = 3 independent replicates ± SD.
(C) Superoxide anion content normalized to cell number. n = 5 independent replicates ± SD.
(D) Percentage of cells positive for reacted dihydrorhodamine was recorded on a flow cytometer. n = 5 independent replicates ± SD.
(E) qPCR for the determination of Sod2 and Cat mRNA levels after 5 days of Glc exposure. n = 3 independent replicates ± SD.
(F) SOD activity was measured after 5 days and normalized to protein content. n = 5 independent replicates ± SD.
(G) CAT activity is also increased in a Glc-dependent manner. n = 5 independent replicates ± SD.
*p < 0.05, one-way ANOVA versus 5.5 mM Glc at 24 hr; Dp < 0.05, one-way ANOVA versus 5.5 mM Glc at 5 days. Glc, glucose; SOD, superoxide
dismutase; CAT, catalase; RLU, relative light units; DHR, dihydrorhodamine.(JNK), and transcriptional regulation of p21cip1 and p27kip1
through FOXO1, FOXO3a, and b-catenin (bcat) produces
the proliferation inhibition caused by hyperglycemia.RESULTS
Exposure to Varying Glc Concentrations Modulates
Proliferation
Wehypothesized that prolonged exposure to a hyperglyce-
mic environment (25 mM) would be able to better mimic
the effects of Glc on the early embryo than short-term
treatment (Kim et al., 2006). To test this hypothesis, we
cultured ESCs in four different Glc concentrations (1, 5.5,
25, and 55 mM) and compared their phenotypes. Cultures
exposed to 25 mM Glc for 24 hr appeared more densely
populated compared with cells cultured in all other Glc56 Stem Cell Reports j Vol. 7 j 55–68 j July 12, 2016concentrations (Figure 1A), supporting the previously
described highly proliferative nature of short-term Glc-
challenged cells (Kim et al., 2006). However, as the cells
continued in the hyperglycemic environment, the pattern
appeared to reverse, with cultures in physiological Glc
(5.5 mM) containing more colonies. Cell counts and
doubling times (Figures 1B, S1A, and S1B) confirmed that
cells in 25 mM Glc initially proliferated more, while fewer
cells were counted after longer treatment. Taken together,
these data demonstrate that murine ESCs treated with
Glc for longer periods in vitro do exhibit similar growth de-
fects as found during ESC derivation.
Hyperglycemia Results in Increases in Oxidative Stress
and Induces Activation of ROS-Removal Enzymes
After confirming that exposure to varying Glc did not alter
expression of advanced glycation end products and their
Figure 2. Hyperglycemia Promotes FOXO Activation
ESCs were exposed to various Glc concentrations for 5 days.
(A) qPCR analysis of FoxO genes. n = 3 independent replicates ± SD.
(B) Western blot on nuclear cell lysates.
(C) Immunocytochemistry demonstrating an increase in nuclear FOXO1 and FOXO3a localization with 25 mM Glc treatment.
(D and E) qPCR analysis of Sod2 (D) and Cat (E) expression following exposure of the indicated cell lines to Glc with or without antioxidants.
n = 3 independent replicates ± SD.
(F and G) SOD (F) and CAT (G) activity. n = 5 independent replicates ± SD.
(H) Superoxide anion and hydrogen peroxide content in the above conditions. n = 5 independent replicates ± SD.
*p < 0.05, one-way ANOVA compared with 5.5 mM Glc; Dp < 0.05, Student’s t test compared with WT. CAT, catalase; DHR, dihydrorhod-
amine; Glc, glucose; GSH-OEt, glutathione reduced ethyl ester; RLU, relative light units; SOD, superoxide dismutase; TBP, TATA binding
protein; VitE, vitamin E; WT, wild-type.cognate receptors (Figure S1B), we sought to determine
whether the Glc-induced generation of ROS (Zhang et al.,
2010) and downstream cell-cycle inhibition were a poten-
tial mechanism for the Glc-induced growth defect. When
cells were exposed to hyperglycemic conditions, their
levels of superoxide anion (O2
∙) and hydrogen peroxide
(H2O2) initially increased in a Glc-dependent fashion, but
over time ROS levels declined, in a pattern similar to the
one observed for proliferation (Figures 1C and 1D).
In concordance with the switch in ROS regulation during
acute Glc exposure, the mRNA expression levels and
enzyme activities of two ROS-removal enzymes, superox-
ide dismutase (SOD) and catalase (CAT), were elevated in
the hyperglycemic condition (Figures 1E–1G and S1D),
suggesting that cells in the hyperglycemic environment
adapted to Glc-induced increases in ROS by activating en-
zymes responsible for their removal.Increases in ROS Levels Promote FOXO1 and FOXO3a
Expression and Nuclear Localization
After observing that oxidative stress pathways were altered
by culture in hyperglycemia, we hypothesized that an
upstream regulator may be altered by the increased Glc
levels and that this may be leading to changes in down-
stream oxidative stress pathways. Initial PCR screens of
possible regulators revealed that FoxO1 and FoxO3a, which
encode for proteins that are known to be involved in
ROS removal and cell-cycle control (Essers et al., 2004),
showed increased transcription upon exposure of cells to
25 mM Glc while the FoxO4 isoform showed an inverse
pattern (Figure 2A). Because FOXO1 and FOXO3a are
important for maintaining ESC phenotypes (Zhang et al.,
2011) and because their mRNA expression was stimulated
under hyperglycemic conditions, we focused on these iso-
forms in subsequent analyses. Western blot analysis andStem Cell Reports j Vol. 7 j 55–68 j July 12, 2016 57
immunostaining confirmed increased nuclear shuttling
and localization of FOXO3a in 25 mMGlc, while increased
FOXO1 nuclear levels seem to be at least partially explain-
able by Glc-mediated increases in overall protein levels
(Figures 2B, 2C, and S2A).
Because FOXO nuclear shuttling is initiated by elevated
levels of ROS, we treated cells with glutathione reduced
ethyl ester (GSH-OEt) and another antioxidant, vitamin E
(VitE), and measured nuclear levels of the two FOXOs as
well as levels of ROS-removal enzymes to determine
whether increases in Sod2 and Cat expression were due to
ROS-induced nuclear shuttling of FOXO. Antioxidant
treatment attenuated Glc regulation of FOXO nuclear
levels (Figure 2B) and reversed the pattern of Glc regulation
of Sod2 and Cat (Figures 2D and 2E). GSH-OEt treatment
also prevented the Glc regulation of SOD and CAT activity,
illustrating that Glc-dependent differences in the activity
of these proteins are mediated through changes in ROS
levels (Figures 2G and 2H).
To confirm FOXO involvement in regulation of the
oxidative stress response, we used a FoxO1- and FoxO3a-tar-
geting short hairpin RNA (shRNA) to knock down both
FoxO1 and FoxO3a (Figure S2B). Similar to the antioxidant
treatment, FoxO1/3 knockdown reversed or attenuated the
trend of Glc regulation of Sod2 and Cat mRNA expression
and SOD and CAT activity (Figures 2D–2G).
Congruent with a role for FOXOs in Sod2 and Cat tran-
scription, sh-FoxO1/3 cells showed lower overall mRNA
levels than wild-type (WT) cells. However, this only trans-
lated intooverall decreasedSODactivity levelswhileCATac-
tivity was globally increased. This global increase was also
noted in Cat mRNA levels when cells were treated with
GSH-OEt. Together, these data could suggest that Glc-medi-
ated oxidative stress, in addition to activating nuclear
FOXOs,may lead to the activation of one ormore transcrip-
tion factors repressive on the Cat promoter and that this
repression is lifted under antioxidant treatment. We have
preliminary evidence that the identity of this transcription
factor could be TCF7L1, formerly known as TCF3. TCF7L1
nuclear levels are increased in 25 mM Glc, and an overex-
pression of a dominant negative form of this transcription
factor inhibits Cat mRNA expression in all Glc concentra-
tions (Figure S3). The combined action of FOXO and
TCF7L1 may culminate in the increased CAT activity
observed. Consistent with these findings, sh-FoxO1/3 cells
exhibited a significant decrease in H2O2 levels (Figure 2H).
FOXO1/3a Inhibit Proliferation in Hyperglycemia by
Regulating Gene Expression of Cell-Cycle Inhibitors
In addition to Sod2 and Cat, FOXO proteins are known to
influence mRNA expression encoding for many other pro-
teins. To determine whether Glc-induced activation of
FOXOs would alter expression and activity of other known58 Stem Cell Reports j Vol. 7 j 55–68 j July 12, 2016FOXO downstream targets, we used qPCR analysis to mea-
sure mRNA levels of PA26, Sirt1, and Gadd45 (Figure 3A) as
well as the cyclin-dependent kinase inhibitors (CKIs)
p21cip1 and p27kip1 (Figures 3B and 3C) in different Glc con-
centrations. Expression of all five FOXO targets measured
increased with increasing Glc concentration, indicating
that Glc-induced changes in nuclear FOXOs may lead to
differential expression of all these target genes.
To more closely monitor whether hyperglycemia may be
affecting cell-cycle regulation through p21cip1, we trans-
fected ESCs with a p21-luciferase reporter construct and
measured luciferase activity in cells from different Glc con-
centrations (Figure 3D). Luciferase activity was Glc-depen-
dently increased in p21-luc cells while no effect was seen in
cells transfected with a mutated p21 promoter (p21mut-
luc) or mock-transfected cells, indicating that hyperglyce-
mia may increase p21cip1 promoter activity leading to
inhibition of the cell cycle and thus a decrease in overall
cell numbers (Figure 3E), seemingly independent of p53
activation, another known regulator of p21cip1 (el-Deiry
et al., 1993). In line with these findings, the mitotic index
and the embryoid body-forming ability of ESCs exposed to
25 mM Glc was decreased when compared with cells
exposed to physiological Glc concentrations (Figures 3F
and 3G). An analysis of the cell cycle revealed that fewer
of the cells cultured in 25 mM Glc were in S phase (Fig-
ure 3H). Together, these data demonstrate that Glc-depen-
dent increases in expression of CKIs inhibit cell-cycle
progression at the G1-S phase transition, leading to a
decrease in cell number.
To determinewhether Glc-induced increases in ROSwere
upstream of the observed changes in cell-cycle regulation,
we next treated cells with the antioxidants VitE or GSH-
OEt. qPCR analysis revealed that antioxidant treatment
reversed Glc-dependent CKI expression patterns, indi-
cating that Glc-induced changes in their expression corre-
lated with higher ROS levels (Figures 3B and 3C). In
addition, antioxidant treatment rescued the S/G1 ratio of
cells cultured in 25 mM Glc to levels found in 5.5 mM Glc
(Figure 3H), further supporting the conclusion that a Glc-
mediated increase in ROS decreases cellular proliferation.
To examine whether FOXO activation linked the Glc-
induced increases in ROS to p21cip1 and p27kip1 expression
and cell-cycle inhibition, we repeated experiments with
sh-FoxO1/3 ESCs. FoxO1/3 knockdown caused a decrease
in p21cip1 and p27kip1 expression with increasing Glc levels,
a pattern similar to the one seen in antioxidant-treated cells
(Figures 3B and 3C), but reversed fromWT, untreated cells.
Cell-count experiments confirmed that sh-Foxo1/3 ESCs
exposed to hyperglycemic conditions were more prolifera-
tive thanWTcells exposed to hyperglycemia or sh-FoxO1/3
ESCs cultured in physiological Glc (Figure 3E). Further-
more, the increased S/G1 ratio in sh-FoxO1/3 cells indicates
Figure 3. Cell Cycle Is Inhibited in Response to Long-Term Exposure to High Glc
(A) qPCR analysis demonstrates a Glc-dependent increase in expression of the FOXO targets PA26, Sirt1, and Gadd45. n = 3 independent
replicates ± SD.
(B and C) qPCR demonstrating a Glc-dependent increase in the cell-cycle regulators p21cip1 and p27kip1. n = 3 ± SD.
(D) p21-luc reporter activity is increased in 25 mM Glc conditions. n = 3 independent replicates ± SD.
(E) Cell numbers in WT and sh-FoxO1/3 ESCs. n = 3 independent replicates ± SD.
(F) Mitotic index.
(G) Embryoid body formation assay. n = 3 independent replicates ± SD.
(H) S/G1 ratio calculated from cell-cycle analysis using propidium iodide. All analyses were performed after 5 days of Glc exposure.
*p < 0.05, one-way ANOVA compared with 5.5 mM Glc. Dp < 0.05, one-way ANOVA compared with p21-luc. Glc, glucose; WT, wild-type; VitE,
vitamin E; GSH-OEt, glutathione reduced ethyl ester; EB, embryoid body.a rescue of proliferation in hyperglycemic sh-Foxo1/3 ESCs
(Figure 3H). In summary, these data demonstrate the
importance of FOXOs in regulating cell-cycle progression
downstream of ROS through regulation of p21cip1 and
p27kip1 mRNA expression.
The FOXO-Mediated Glc Response Is Dependent on
Suppression of AKT and Activation of JNK
In adult stem and somatic cells, FOXO nuclear import and
export is mediated by AKT and JNK 1 and 2 (Liang andSlingerland, 2003; Oh et al., 2005; Wang et al., 2012).
While nuclear AKT levels are positively regulated by Glc
to support FOXO nuclear exclusion (Dickson et al., 2001),
JNK1/2 are activated in response to oxidative stress to pro-
mote FOXO nuclear import (Martindale and Holbrook,
2002). Western blot analysis of ESCs demonstrated that
the activating phosphorylation on the S473 residue of
AKT was reduced in 25 mM Glc and correlated with lower
levels of nuclear AKT (Figure 4A). In contrast, the activating
T183/Y185 phosphorylation of JNK1/2 was increased inStem Cell Reports j Vol. 7 j 55–68 j July 12, 2016 59
Figure 4. AKT and JNK Oppositely Regulate the Long-Term Glc Response in ESCs
(A–D) Western blots on whole cell lysates or nuclear fractions as indicated.
(E) Cells were immunostained for FOXO3a and counterstained with DAPI.
(F) qPCR analysis for FOXO target genes determined with the 2DDCt method and correction for PCR efficiency using Tbp as the housekeeper.
n = 3 independent replicates ± SD.
(G) Percentage of cells in cell-cycle stages were measured with flow cytometry using propidium iodide-treated cells and S/G1 ratios
calculated. n = 3 independent replicates ± SD.
(H and I) SOD (H) and CAT (I) activity is increased in AKT-inhibited cells, similar to cells exposed to 25 mM Glc alone. n = 5 independent
replicates ± SD.
(J) Superoxide anion levels. n = 5 ± SD.
(K) Hydrogen peroxide levels. n = 5 independent replicates ± SD.
*p < 0.05, one-way ANOVA versus 5.5 mM Glc; Dp < 0.05, one-way ANOVA versus 25 mM Glc. 124005, AKT inhibitor; CAT, catalase; DHR,
dihydrorhodamine; Glc, glucose; GSH-OEt, glutathione reduced ethyl ester; RLU, relative light units; SOD, superoxide dismutase; TBP, TATA
binding protein; UT, untreated.
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25mMglucose (Figure 4B). Thus, in response to a hypergly-
cemic environment, cells increase activation of JNK1/2
while decreasing activation and nuclear localization of
AKT, which may result in altered expression of FOXO pro-
teins and, thus, downstream effects on ROS removal and
cell-cycle progression. Phosphorylation of both proteins
was either normalized or abolished upon antioxidant treat-
ment, suggesting that their phosphorylation levels were
regulated by the oxidative stress status of the cell (Figures
4A and 4B).
To examine the effects of altered AKT and JNK activation
on FOXO nuclear localization, FOXO-mediated transcrip-
tion, and cellular response on AKT and JNK, we used a
Jnk1/2 null ESC line and a small-molecule AKT inhibitor,
compound 124005. Western blot analysis confirmed that
treatment with compound 124005 resulted in a decrease
in phosphorylation of AKTat S473 (Figure 4D), a phosphor-
ylation site that is critical for its activity (Sarbassov et al.,
2005). At the same time, there was a noted decrease in
the inhibitory phosphorylation of FOXO3a at S253 in
25 mM Glc and AKT-inhibited 5.5 mM Glc, the residue
known to be phosphorylated by active AKT (Figure 4D).
In addition, an increase in nuclear localization of FOXO3a
was observed upon AKT inhibition in physiological Glc
(Figure 4E), and FOXO3a levels were similar in both
5.5 mM and 25 mM Glc in the Jnk1/2/ ESCs (Figure 4C).
Similarly, AKT inhibition also decreased phosphorylated
FOXO1 levels over non-treated 5.5-mMGlc cells. However,
contrary towhatwas expected from thewestern blot results
of nuclear 25-mMGlc-challenged cells, which had shown a
nuclear increase in FOXO1 levels, the levels of phosphory-
lated FOXO1 were higher in the 25-mM Glc condition.
To demonstrate that the changes mediated by AKT
inhibition and Jnk1/2 knockout resulted in downstream
changes in FOXO target gene expression, we used
qPCR analysis to measure the expression of Sod2, Cat,
p21cip1, and p27kip1 (Figure 4F). Treatment with 124005 in
5.5 mM Glc increased expression of these FOXO targets,
mimicking expression in the 25-mM Glc condition. At
the same time we observed a decrease in cellular prolifera-
tion, which may result from the observed increase in
expression of the cell-cycle inhibitors p21cip1 and p27kip1
(Figure 4G). Concomitant with the reduction in mRNA
levels of Sod2 and Cat, AKT inhibition led to a loss of Glc-
mediated increases of O2
∙ and H2O2 levels (Figures 4E
and 4F), which could be mediated by increased SOD and
CAT activity (Figures 4G and 4H), an effect independent
of phosphoinositide 3-kinase (see Figure S3C). In contrast,
Jnk1/2 null ESCs exposed to 25 mM Glc showed increased
levels of p21cip1 and p27kip1, increased proliferation and
decreased levels of Sod2mRNA, a reduction in SOD activity,
and increased O2
∙ levels; these changes are similar to the
phenotype seen in 5.5 mM Glc and in cells treated withantioxidant (Figures 4K and 4L). In summary, both AKT in-
hibition and JNK activation appear to be upstream of the
Glc-mediated nuclear presence of FOXOs, specifically
FOXO3a, and its regulation of target gene promoters.
The only pattern that did not match the hypothesis was
the differential regulation of CatmRNA and activity levels,
which showed increased levels instead of the expected
reduction and caused a decrease in H2O2 production (Fig-
ures 4F, 4I, and 4L). We conclude that, although JNK may
generally contribute to the FOXO-mediated regulation of
Cat, additional factors may play roles in the regulation of
Cat during oxidative stress response of ESCs that coun-
teract FOXOs.
FOXO3a/CTNNB1 Interaction Is Increased in
Hyperglycemia
Although FOXO3a regulation of Sod2 and p27kip has been
well studied for many years, recent reports suggest that
FOXO3a binding to the bcat protein, CTNNB1, is necessary
for its role as a transcriptional activator of downstream
target genes (Hoogeboom et al., 2008), and roles for
CTNNB1 in regulating oxidative stress and the cell cycle
have been described (Behrens and Lustig, 2004; Boo et al.,
2009; Essers et al., 2005). However, their co-occupation of
target gene promoters has not been conclusively shown.
To determinewhetherCTNNB1maybe binding to FOXO3a
and mediating the Glc-dependent changes in cell-cycle
regulation and oxidative stress management we observed,
we first investigated the expression and activity levels of
CTNNB1 in different Glc concentrations. Phosphorylation
of the CTNNB1 residues Y142 and Y654 that promote
nuclear translocationwere increased in hyperglycemic con-
ditions (Figure 5A), which coincided with a Glc-dependent
increase innuclearCTNNB1 levels (Figures5A,5B, andS2A).
AKT Is Upstream of FOXO, but Not CTNNB1
In addition to its role in regulating FOXO nuclear localiza-
tion, active AKT has been positively correlatedwith nuclear
accumulationofCTNNB1bybothdirect and indirectmech-
anisms. AKT has been shown to directly phosphorylate
CTNNB1 on S552, which leads to stabilization, nuclear
accumulation, and activation of CTNNB1 target genes
(Taurin et al., 2006; Fang et al., 2007; He et al., 2007).
Furthermore, AKT may phosphorylate and thereby inacti-
vate GSK3b, a member of the CTNNB1 destruction com-
plex, resulting in CTNNB1 accumulation and nuclear
shuttling (Lawlor and Alessi, 2001). To test whether AKT
was responsible for the noted increase in nuclear CTNNB1
by either mechanism, we next determined the levels of spe-
cificphospho formsofCTNNB1withandwithoutAKT inhi-
bition. CTNNB1 phosphorylation on S552 was observed in
5.5mMGlc but not in 25mMGlc (Figure 5C), which corre-
lates with the increased AKTactivation observed in 5.5mMStem Cell Reports j Vol. 7 j 55–68 j July 12, 2016 61
Figure 5. Glc Increases CTNNB1 Activity and Interaction with FOXO1 and FOXO3a
(A) Western blots demonstrating an increase in the active and phosphorylated form of CTNNB1, and an increase in its nuclear localization
in cells exposed to 25 mM Glc for 5 days.
(B) Cells were immunostained with anti-CTNNB1 and nuclei counterstained with DAPI.
(C) Western blots demonstrating the effect of AKT inhibition on CTNNB1 phosphorylation.
(D) Immunoprecipitation studies demonstrating an increase in FOXO/CTNNB1 interaction with increasing Glc. Top panel shows repre-
sentative images of densitometry studies shown in bottom panel (n = 3 independent replicates ± SD). *p < 0.01, one-way ANOVA versus
5.5 mM Glc.
(E) FOXO3a/CTNNB1 occupation of promoters of FOXO target genes increased in response to Glc, an effect not seen in sh-FoxO1/3 ESCs. WT,
wild-type; Glc, glucose; TBP, TATA binding protein; IgG, immunoglobulin G; ChIP, chromatin immunoprecipitation; IP, immunoprecipi-
tation; IB, immunoblot.
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Figure 6. Proposed Mechanism of Glc
Action
Exposure to diabetic Glc leads to an imme-
diate increase in ROS generation and sub-
sequent JNK activation and results in the
nuclear activation of FOXO3a/CTNNB1 by
5 days of exposure. This leads to the local-
ization of this complex to the promoters of
genes that regulate ROS removal and the cell
cycle. In addition, AKT remains inactive in
these conditions, rendering it unable to
promote FOXO3a removal from the nucleus.
CKI, cyclin-dependent kinase inhibitor; Glc,
glucose; ROS, reactive oxygen species.Glc (Figure 4A). Because nuclear accumulationofCTNNB11
was increased in 25mM rather than 5 mMGlc and because
inhibitionofAKTdidnot alterCTNNB1phosphorylation at
S552, AKT does not appear to be responsible for this phos-
phorylation and subsequent nuclear accumulation.
To determine whether AKT regulates nuclear accumula-
tion of CTNNB1 indirectly through GSK3b, we measured
levels of CTNNB1 phosphorylated at residues S33/37/T41,
the GSK3b phosphorylation sites, in control and AKT in-
hibitor-treated cells. AKT inhibition did not alter CTNNB1
phosphorylation at S33/37/T41, which demonstrates that
AKTdoesnot regulateCTNNB1 throughGSK3b (Figure 5D).
However, there was an overall decrease in CTNNB1 phos-
phorylation at residues S33/37/T41 in 25 mM Glc, illus-
trating that in the hyperglycemic condition less CTNNB1
is tagged for degradation, which may allow the protein to
accumulate in the nucleus in 25 mM Glc (Figure 5C,
compare with Figure 5A).
These data indicate that AKT inhibition in physiological
Glc conditions does not alter CTNNB1 phosphorylation on
residues S552 and S33/37/T41 or its cellular localization,
but that decreases in GSK3b inhibition possibly contribute
to the higher levels of nuclear CTNNB1 in 25 mM Glc.
FOXO3a/CTNNB1 Complex Is Present on the
Promoters of Genes that Regulate ROS Removal and
Cell-Cycle Inhibition
Because both FOXOs and CTNNB1 are recruited to the nu-
cleus in hyperglycemic conditions, we next investigated
whether these proteins associate in complexes. Co-immu-
noprecipitation analysis demonstrated that CTNNB1/
FOXO1 and CTNNB1/FOXO3a complexes were increased
in 25 mM Glc (Figure 5D), suggesting that these proteinsmay work together to affect transcription of target genes.
However, the FOXO3a/CTNNB1 complex was more abun-
dant than the FOXO1/CTNNB1 complex, suggesting that
the transcriptional responses observed may have primarily
been mediated by FOXO3a. To determine whether the
observed nuclear FOXO3a/CTNNB1 complexes were in
fact altering transcription of target genes, we used sequen-
tial chromatin immunoprecipitation (ChIP) to quantify
FOXO3a/CTNNB1 binding to the promoters of p21cip1,
p27kip1, and Sod2. We observed a Glc-dependent increase
in localization of this complex to the promoters of these
genes (Figure5E),whichcorrelateswith the increase in inter-
action between these two proteins in 25 mM Glc. This in-
crease in localization of transcription factor complexes to
target genepromotersmaybe responsible for theGlc-depen-
dent changes in expression observed in the cells. This
binding pattern is abolished in sh-FoxO1/3 cells, further
confirming the importance of the FOXO3a/CTNNB1 inter-
action in regulating ROS removal and cell-cycle regulation
(Figure 6). However, it appears that there is still binding at
the p27kip1 promoter, either suggesting different affinities
for binding todifferent promoters or that theChIP antibody
employed may also be recognizing another protein. Thus,
these results provide direct evidence that the promoters of
p21cip1 and Sod2 are regulated by a FOXO3a/CTNNB1 com-
plex, but we cannot ultimately conclude that FOXO3a and
CTNNB1 are co-binding at the p27kip1 locus.DISCUSSION
Our results have shown that exposure of ESCs to high Glc
levels leads to an oxidative stress response, resulting inStem Cell Reports j Vol. 7 j 55–68 j July 12, 2016 63
repression of AKT, phosphorylation of JNK, and subse-
quent activation of FOXO1 and FOXO3a. Simultaneously,
elevated levels of CTNNB1 are found in the nucleus, but
this increase in nuclear accumulation is independent of
AKT. The increased nuclear presence of FOXOs and
CTNNB1 increases the levels of nuclear FOXO/CTNNB1
complexes, which co-occupy target gene promoters
responsible for ROS removal and cell-cycle inhibition.
Molecularly, we suggest FOXO transcription factors as
the mediators for the noted reduction in proliferation
and the upregulation of ROS-removal enzymes (Figure 6).
Previous studies have identified FOXO3a as a key regulator
of Sod2 (Kops et al., 2002), p27kip1 (Dijkers et al., 2000), and
p21cip1 expression (Hauck et al., 2007). Here, an shRNA-
mediated knockdown of FoxO1/3 led to a major decline
in FOXO3a binding to these promoters. Interestingly, there
was still FOXO3a binding observed on the promoters of
these genes, which may be due to the fact that the knock-
down was not 100% effective.
The combined regulation of p27kip1 and Sod2 by FOXO4
and CTNNB1 has been suggested through promoter re-
porter studies (Essers et al., 2004), but direct evidence of
FOXO/CTNNB1 binding to these promoters through
ChIP has so far been lacking; however, such evidence is pro-
vided here for Sod2 and also additionally for p21cip1. In
addition, we show here that this binding is dependent on
Glc-induced ROS levels, which has widespread implica-
tions not only for the routine culture of pluripotent stem
cells but also for the field of diabetes and aging.
There are multiple ways whereby oxidative stress may
promote FOXO activation. For example, FOXO proteins
can directly sense ROS through the ability of ROS to induce
disulfide bridges between cysteine residues on the FOXO
protein, resulting in FOXO activation and transcription
of ROS-removal enzymes (Dansen, 2011). However, while
this would explain the noted increase in FoxO1 and FoxO3a
nuclear localization, it does not explain the Glc-dependent
increase in FoxO1 and FoxO3a mRNA expression that was
also observed. Nonetheless, the Glc-mediated FoxO1 and
FoxO3amRNA induction could potentially be due to a pre-
viously described relationship between ROS, phosphory-
lated JNK, and FoxO transcription (Essers et al., 2004)
that goes beyond the protein level investigated here.
Furthermore, treatment with antioxidants in this study
reversed the Glc-dependent increase in FOXO3a nuclear
localization and Sod2 and Cat expression, suggesting that
the generation of excess ROS is indeed upstream of
FOXO3a target expression. Interestingly, treatment with
antioxidants led to a global increase in CAT activity that
was unexpected, but could be due to the alleviation of
TCF7L1-regulated repression following antioxidant treat-
ment, leading to an increase in gene expression (Solberg
et al., 2012).64 Stem Cell Reports j Vol. 7 j 55–68 j July 12, 2016An unanswered question remains the identity of the ki-
nase responsible for nuclear CTNNB1 accumulation. Our
data suggested that it is not AKT. Treatment with the AKT
inhibitor 124005 in physiological Glc conditions resulted
in an increase in nuclear FOXO3a, but did not affect
CTNNB1 nuclear localization, demonstrating that nuclear
CTNNB1 localization in hyperglycemia is independent of
AKT inhibition. These data are inconsistent with previous
findings, as AKT has been shown to promote an increase
in CTNNB1 transcriptional activity through the phosphor-
ylation of S552 (Fang et al., 2007) and also to inhibit
GSK3b, which normally phosphorylates CTNNB1 on S33/
37/T41, tagging it for degradation (Shiojima and Walsh,
2006; Srivastava and Pandey, 1998). One possible explana-
tion for this could be the existence of different pools of
CTNNB1 that are regulated independently of one another
(Mbom et al., 2013), or perhaps that CTNNB1 is regulated
differently in stem cells than in other cell types.
Our findings also raise questions regarding current ESC
culture techniques. Routinely used media contain 25 mM
Glc, and it is often observed that there is a tremendous
amount of spontaneous differentiation and that ESCs
behave differently from passage to passage. In fact, one
study demonstrated that the derivation and culture of
ESCs in physiological Glc reduced oxidative stress and
improved proliferative capacity (Wang et al., 2006) while
a different study confirmed that exposure to oxidative
stress promoted cell-cycle arrest and senescence (Guo
et al., 2010). Our contribution here is to have provided a
molecular consequence of oxidative stress on ESCs, medi-
ated through FOXO3a activation and AKT inhibition.
Recent studies have demonstrated that FOXOs are impor-
tant in ESC identity, with FOXO1 being a positive regulator
in the maintenance of pluripotency, while the role of
FOXO3a remains elusive (Zhang et al., 2011) and stimula-
tion of AKT in ESCs promotes proliferation (Heo and
Han, 2006). Our results are consistent with these reports,
demonstrating that hyperglycemia results in an increase
in oxidative stress that leads to changes in the proliferative
capacity of pluripotent cells mediated partly through the
activation of FOXO3a downstream of AKT and JNK
regulation.
Conclusion
Our findings demonstrate that early exposure to high Glc
levels stimulates an oxidative stress response that promotes
the expression and activity of ROS-removal enzymes, pro-
tecting the embryonic cells from ROS-induced damage.
At the same time this leads to an increase in expression of
cell-cycle regulatory genes, inhibiting the proliferative ca-
pacity of these cells. By extension, our data are relevant
for early pre-implantation embryos ofmothers with pre-ex-
isting diabetes developing proliferative defects.
EXPERIMENTAL PROCEDURES
Cell Culture
Mouse ESC lines D3 and CCE were maintained in the undif-
ferentiated state on BD Falcon Primaria tissue culture flasks
(BD Biosciences) in medium containing 1,000 U/ml Leukemia
Inhibitory Factor (Chemicon). Cell-culture medium contained
15% fetal bovine serum (FBS) (PAA), 0.1 mM non-essential amino
acids, 50 U/ml streptomycin and 50 U/ml penicillin, and 0.1 mM
b-mercaptoethanol (Invitrogen) diluted in DMEM (Invitrogen).
Cells were passaged every 48 hr using 0.25% trypsin-EDTA (Invi-
trogen). Cell numbers were determined using a CASYcell counter
(Innovates).
Reporter and Knockdown ESC Lines
The p21-luc and p21mut-luc ESC lines were created by transfecting
luciferase reporter constructs containing various portions of
the human p21 promoter (2.15 kb [p21Dp53] and 93 bp
[p21P93-S]) (Datto et al., 1995) at the passage of analysis using Ef-
fectene (zur Nieden et al., 2005; Ding et al., 2012). For creation of
shRNA-mediated knockdown FoxO1/3 ESCs, a pSuperior-FoxO1/3
plasmid (de Keizer et al., 2010) was linearized with HindIII, gel
purified, and 1 mg transfected into ESCs using Effectene. Clones
were chosen after 72 hr of puromycin selection, and plasmid
integration was confirmed using PCR for the puromycin gene (for-
ward primer 50-TGCAAGAACTCTTCCTCACG-30, reverse primer
50-AGGCCTTCCATCTGTTGCT-30) with an annealing temperature
of 65C. Western blotting was used to estimate the percentage of
knockdown. The Jnk1/2/ ESC line was a kind gift of Rodger J.
Davis (University of Massachusetts Medical School).
Glc and Compound Treatment
Culture medium was made from no-Glc DMEM (Invitrogen) con-
taining the above cell-culture supplements with the addition of
the appropriate amount of Glc. Stock solutions of 10 mM AKT
Inhibitor I (Calbiochem, 124005) dissolved in DMSO were diluted
for a final treatment concentration of 5 mM. A solvent negative
control was tested alongside inhibitor treatment. Antioxidant
treatment consisted of glutathione reduced ethyl ester (GSH-OEt,
250 mmol/l) or vitamin E (VitE, 1 mg/ml).
Protein Extraction and Western Blotting
Sodium orthovanadate-pretreated cells (30 min) were trypsinized
and lysed in radioimmunoprecipitation assay (RIPA) buffer
(1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS in 13 PBS
[pH 7.4]) containing a protease inhibitor cocktail (104 mM AEBSF,
80 mM aprotinin, 4 mM bestatin, 1.4 mM E-64, 2 mM leupeptin,
1.5mMpepstatin A [Sigma-Aldrich]). Fractionated protein samples
were preparedwith anNE-PER cell fractionation kit (Pierce, 78833)
and protein quantified using the DC protein assay (Bio-Rad). Pro-
tein (25 mg) was loaded on an SDS-PAGE gel and transferred to a
polyvinylidene fluoride membrane overnight at 30 V and 4C.
Membranes were blocked in 5% BSA diluted in 13 TBST (Tris-buff-
ered saline with Tween 20) for 1 hr at room temperature, and incu-
bated with primary antibody at 4C. Membranes were washed,
incubated with secondary antibody, and developed using
SuperSignal West Pico Chemiluminescent Substrate (Pierce). Thefollowing antibodies were used: ACTINB (#8456), pan AKT
(#4691), phospho AKTS473 (#4060), anti-rabbit HRP (#7074), and
anti-mouse HRP (#7076) (all from Cell Signaling Technology);
pan CTNNB1 (#ab16051), phospho CTNNB1Y142 (#ab27798),
phospho CTNNB1Y654 (#ab59430), pan FOXO3a (#ab47409),
phospho FOXO3aS253 (#ab47285), phospho JNK1/2T183/Y185
(#ab4821), pan JNK1/2 (#ab112501), and TBP (#ab818) (all from
Abcam).
Immunocytochemistry
Cells were fixed in 7:3 acetone/methanol for 5–10 min at 20C.
Cell membranes were permeabilized with 0.1% Triton X-100 in
PBS for 15 min at room temperature. Non-specific binding was
blocked with 10% FBS, 0.5% BSA in PBS for 30 min at 37C. Pri-
mary antibody was diluted in blocking buffer and incubated over-
night at 4C. Plates were incubated with secondary antibody and
DAPI for 2 hr at room temperature. The following antibodies
were used: pan CTNNB1 (Life Technologies, #71-2700), pan
FOXO3a (Abcam, #ab47409), anti-mouse Alexa Fluor 488 (Life
Technologies, #MHZAP7020), and anti-rabbit Alexa Fluor 546
(Life Technologies, #A-11035).
Superoxide Anion and Hydrogen Peroxide
Quantification Assays
Superoxide anion and hydrogen peroxide content were measured
using dihydrorhodamine 123 (DHR; Cayman Chemical) and the
Superoxide Anion Detection Kit (Agilent) as per manufacturer’s
instructions. Light emission for superoxide anion content was re-
corded with a Lucetta luminometer (Lonza) and data were normal-
ized to the total cell number collected.
Luciferase Activity Assay
Luciferase activity was assayed with the luciferase assay system
from Promega. Cells were lysed in Luciferase Cell Culture Lysis
53 Reagent. Lysates were cleared by centrifugation (12,000 3 g
for 2min at 4C) and luminescence read in a Lucetta Luminometer
(Lonza).
SOD and CATActivity Assays
RIPA protein lysateswere assessed for SOD andCATactivity accord-
ing to the manufacturer’s instructions (Cayman Chemical). Pro-
tein content was quantified with a Lowry assay and used to
normalize enzyme activity.
Flow Cytometry
The percentage of marker-positive cells in single-cell suspensions
were gated based onWTor non-reacted cells. Ten thousand events
were measured in a Beckman Coulter flow cytometer and mean
percentages of GFP/marker-positive cells were calculated from
three independent treatments.
RNA Extraction and cDNA Synthesis
RNA was extracted using the Nucleospin RNA extraction kit (Ma-
cherey Nagel) following the manufacturer’s instructions, and
quantified using a Nanodrop spectrophotometer (ND-1000; Nano-
drop). 625 ng of mRNA was used for cDNA synthesis in a reactionStem Cell Reports j Vol. 7 j 55–68 j July 12, 2016 65
containing 0.5mMdeoxynucleoside triphosphates, 0.3 mg random
hexamers, 100 mM DTT, 5 mM MgCl2, 50 U of RNase inhibitor,
and 80 U of reverse transcriptase (Fermentas).
RT-PCR and qPCR
Gene-expression analysis was done from 25–50 ng of cDNA using
RT-PCR as described previously (zur Nieden et al., 2007). Final PCR
products were run on an agarose gel containing ethidiumbromide.
qPCR was performed using an iCycler iQ system and SYBR Green
PCR master mix (Bio-Rad) with post-run melting curves. For the
initial 5-min denaturation step, the temperature was maintained
at 95C and the machine cycled between 30 s at 95C and 45 s at
the appropriate annealing temperature for 40 rounds. Data were
then analyzed according to the 2DDCt method with correction
for PCR efficiency (Pfaffl, 2001) and normalization to Tbp, and ex-
pressed as n-fold change over 25 mMGlc (if not noted otherwise).
Primers used are listed in Table S1.
Cell-Cycle Analysis
Ethanol (70%)was added to trypsinized cells in a dropwise fashion.
Following a 60-min incubation in ethanol, sampleswere incubated
in propidium iodide for 3 hr at 4C, spun down, washed, and
analyzed by flow cytometry.
Co-immunoprecipitation
Nuclear protein (60 mg) was mixed with an equal volume of Ag/Ab
buffer (50 mM Tris [pH 8.0], 1 mM EDTA, 0.2 mM EGTA, 1 mM
DTT, 10% glycerol) andmixed with 4 mg of anti-CTNNB1 antibody
(Abcam, #ab2365) with gentle agitation for 1 hr at 4C. Fiftymicro-
liters of Protein A Sepharose beads (1:1 slurry in PBS) was then
added for an additional 3 hr at 4C with gentle agitation. Beads
were washed three times in 0.01% NP-40 buffer (1 mM Tris-Cl
[pH 8.0], 2.4 mMNaCl, 0.01% NP-40), followed by two additional
washes in PBS. Proteins were eluted adding SDS-PAGE loading
buffer and subjected to 95C for 10 min. The 6%/10% SDS-PAGE
gel was run for approximately 3 hr at 100 V and the western blot
for FOXOs was continued as described above.
Sequential Chromatin Immunoprecipitation
Crosslinking was performed in 1% paraformaldehyde (15 min,
roomtemperature) and stoppedwith0.125Mglycine (5min).Cells
were lysed in PBS containingphosphatase inhibitormix (PI, Sigma-
Aldrich) and 1mMPMSF, and the pellet was resuspended in 1ml of
ChIP sonication buffer (50 mM HEPES [pH 7.9], 140 mM NaCl,
1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1%
SDS) also containing PI and PMSF. DNAwas sheared by sonication
(10 rounds of [10 3 0.5 s on, 0.6 s off, 27% amplitude]) and a
sample was used for determining fragment size. DNA (50 mg) was
then used for two rounds of immunoprecipitation (round 1:
FOXO3a [Santa Cruz, sc-11351]; round 2: CTNNB1 [BD Transduc-
tion Laboratories, 610154]), protein was digested using proteinase
K, and the resulting sample was used for PCR analysis as described
above with primers as listed in Table S2.
Statistics
p Values were calculated with a standard weighted-means ANOVA
when independent treatment groups were compared. Post hoc Tu-66 Stem Cell Reports j Vol. 7 j 55–68 j July 12, 2016key honest significant difference tests were performed when more
than two groups were compared, and the ANOVA yielded a
significant F ratio to determine statistical differences among
two individual groups (http://faculty.vassar.edu/lowry/anova1u.
html). A p value equal to or less than 0.05 was considered statisti-
cally significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and two tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2016.06.006.
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